Health & Fitness
Health and Fitness
Health and Fitness
Thu, February 5, 2009
Wed, February 4, 2009 Incyte to Report 2008 Financial Results and 2009 Financial Guidance and Provide Update on Drug Discovery & Development Programs
WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter and year-end 2008 financial results conference call for 8:30 a.m. ET on Wednesday, February 18, 2009. The schedules for the press release and conference call are as follows:
-- Q4 & YE 2008 Press Release: | February 18, 2009 at 7:00 a.m. ET | |||||||
-- Q4 & YE 2008 Conference Call: | February 18, 2009 at 8:30 a.m. ET | |||||||
-- Domestic Dial In Number: | 877-407-8037 | |||||||
-- International Dial In Number: | 201-689-8037 | |||||||
-- Conference ID # | 312048 | |||||||
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 312048.
The conference call will also be webcast live on CCBN and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for oncology, inflammation and diabetes.
